Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Orthofix sells its sports medicine subsidiary Breg Inc. to private equity subsidiary Breg Acquisition Corp. for $157.5 million in cash.
Wall Street analysts remain confident that Boston Scientific subsidiary Cameron Health’s lead-free implantable cardioverter defibrillator will win FDA approval this week, but some wonder whether the device will appeal to patients.
In an apparent effort to push back against medical device industry lobbying, the FDA crafted an internal report outlining agency successes in keeping "malfunctioning or needlessly invasive high-risk medical devices" off the U.S. market, despite their approval in the European Union.